SCHEMBL6003431

SCHEMBL6003431

C[CH]OCc1csc2ccc(Cl)cc12

nearest known ligand 0.58

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 4/20 0.58
KEAP1 Q14145 1/20 0.52
NFE2L2 Q16236 1/20 0.52
SMN1; SMN2 Q16637 1/20 0.48
CA2 P00918 1/20 0.48
FFAR4 Q5NUL3 1/20 0.45
MAPT P10636 2/20 0.42
EGFR P00533 1/20 0.41
ERBB2 P04626 1/20 0.41
EPHA2 P29317 1/20 0.41
KDR P35968 1/20 0.41
EPHB4 P54760 1/20 0.41
PKM P14618 1/20 0.39
EPHX1 P07099 1/20 0.39
GAB1 Q13480 1/20 0.38
SLC22A12 Q96S37 1/20 0.38
UTS2R Q9UKP6 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1520550 0.80 CYP2A6 (0.68) CYP2A6KEAP1NFE2L2SMN1; SMN2CA2
SCHEMBL2095036 0.80 CYP2A6 (0.63) CYP2A6KEAP1NFE2L2SMN1; SMN2CA2
SCHEMBL6003500 0.78 CYP2A6 (0.55) CYP2A6SMN1; SMN2CA2MAPT
SCHEMBL246112 0.77 CYP2A6 (0.69) CYP2A6KEAP1NFE2L2SMN1; SMN2CA2
SCHEMBL156931 0.77 CYP2A6 (0.69) CYP2A6KEAP1NFE2L2SMN1; SMN2CA2
SCHEMBL29679218 0.77 KEAP1 (0.61) CYP2A6KEAP1NFE2L2SMN1; SMN2CA2
SCHEMBL5541315 0.76 CYP2A6 (0.58) CYP2A6KEAP1NFE2L2SMN1; SMN2CA2
SCHEMBL4418009 0.75 CYP2A6 (0.71) CYP2A6KEAP1NFE2L2SMN1; SMN2CA2
SCHEMBL9883963 0.74 CYP2A6 (0.65) CYP2A6KEAP1NFE2L2SMN1; SMN2CA2
SCHEMBL2949120 0.74 CYP2A6 (0.69) CYP2A6KEAP1NFE2L2SMN1; SMN2CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1678185-A1 2,3-DIHYDRO-6-NITROIMIDAZO [2,1-B] OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2006-07-12 EP disclosed
WO-2005042542-A1 2,3-DIHYDRO-6-NITROIMIDAZO (2,1-B) OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2005-05-12 WO disclosed